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An elevated plasma total homocysteine (tHcy) concentration is a risk factor for cardiovascular
disease and for having offspring with a neural-tube defect. Folate is a methyl donor in the
remethylation of homocysteine into methionine. Although folic acid supplementation decreases
tHcy concentrations, effects of folic acid supplementation on plasma methionine concentrations
are unclear. There is also concern that folic acid supplementation negatively affects vitamin B12
status. We studied effects of low-dose folic acid supplementation on methionine and vitamin B12
concentrations in plasma. We also investigated whether baseline plasma methionine and tHcy
concentrations correlated with the baseline folate and vitamin B12 status. For a period of 4 weeks,
144 young women received either 500 mg folic acid each day, or 500 mg folic acid and placebo
tablets on alternate days, or a placebo tablet each day. Plasma methionine, tHcy and plasma
vitamin B12 concentrations were measured at start and end of the intervention period. Folic acid
supplementation had no effect on plasma methionine or plasma vitamin B12 concentrations
although it significantly decreased tHcy concentrations. Plasma methionine concentrations
showed no correlation with either tHcy concentrations (Spearman r s - 0 × 01, P = 0× 89), or any
of the blood vitamin variables at baseline. Baseline tHcy concentrations showed a slight inverse
correlation with baseline concentrations of plasma vitamin B12 (r s - 0× 25, P , 0× 001), plasma
folate (r s - 0× 24, P , 0× 01) and erythrocyte folate (r s - 0× 19, P , 0× 05). In conclusion, low-dose
folic acid supplementation did not influence plasma methionine or plasma vitamin B12
concentrations. Furthermore, no correlation between plasma methionine concentrations and the
blood folate and vitamin B12 status was shown.
Folic acid: Methionine: Homocysteine: Vitamin B12
Homocysteine has received a lot of attention because
hyperhomocysteinaemia has been shown to be a risk
factor for cardiovascular disease and for having offspring
with a neural-tube defect (Steegers-Theunissen et al. 1994;
Boushey et al. 1995; Mills et al. 1995). Homocysteine is the
transmethylation product of the essential amino acid methio-
nine. Methionine can be transmethylated to homocysteine,
which in turn can be remethylated to methionine. Thus, in
theory, an increase in plasma methionine is expected after a
decrease in plasma homocysteine. N-5-methyltetrahydrofo-
late, the predominant form of the B-vitamin folic acid in the
blood, serves as a methyl donor for this remethylation
reaction and supplementation with folic acid decreases
plasma total homocysteine (tHcy) concentrations (Ward
et al. 1997; Brouwer et al. 1999). Vitamin B12 (methyl-
cobalamin) is a cofactor in this remethylation reaction.
Supplementation with folic acid or vitamin B12 increased
plasma methionine concentrations in folate- or vitamin
B12-deplete subjects (Guttormsen et al. 1996).
Since 1947 there has been concern that folic acid supple-
mentation may have deleterious effects on cobalamin defi-
ciency (Heinle & Welch, 1947). We therefore checked in
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this study whether low-dose folic acid supplementation
influenced plasma vitamin B12 concentrations.
The present study aimed to determine the effects of
low-dose folic acid supplementation on plasma methionine
and plasma vitamin B12 concentrations in healthy volun-
teers. We compared these effects with the decreasing effect
on plasma tHcy concentrations (Brouwer et al. 1999). We
also examined whether plasma methionine and tHcy were
correlated with the blood folate and vitamin B12 status.
Subjects and methods
The methods of this experiment have previously been
described in more detail (Brouwer et al. 1999). In short,
these are as follows.
Subjects
We recruited healthy, non-pregnant women (18–40 years of
age). Exclusion criteria were: smoking, gastrointestinal
disorder, use of vitamins, minerals, yeast or seaweed,
malaria prophylaxes and anti-convulsants. The final study
group comprised 144 women.
The Medical Ethical Committee of the Wageningen
Agricultural University approved the study design. All
women gave written informed consent.
Methods
After stratification for the use of oral contraceptives, the
women were randomized over three intervention groups
and received either 500 mg folic acid/d, or 500 mg folic
acid and a placebo tablet every second day (on average
250 mg folic acid/d), or a placebo tablet daily (Pharma-
chemie B.V., Haarlem, The Netherlands) for 4 weeks. The
group sizes were chosen to detect an 11 % decrease in
plasma tHcy concentrations after 4 weeks of intervention
(Brouwer et al. 1999). The subjects and the laboratory staff
were blind to the group assignment. Subjects followed their
regular diet except for refraining from the consumption of
liver and Marmite, a yeast extract. A 24 h recall was
obtained from each subject once during the intervention
period to check their intake of macronutrients, vitamin B6,
B12 and folate (Stichting NEVO, 1993; Brants & Hulshof,
1995).
Venous blood samples were collected after overnight
fasting at the start (week 0) and at the end of the 4-week
intervention period (week 4). We determined plasma
methionine concentrations and plasma tHcy, plasma
folate, erythrocyte folate and vitamin B12 concentrations
in all samples.
Measurements
Samples for determinations in plasma were immediately
placed on ice and centrifuged within 60 min at 3000 g
for 10 min. Plasma was separated and stored at - 208 for
methionine, at - 358 for folate and vitamin B12 and at
- 808 for tHcy. For determination of folate concentrations
in erythrocytes, whole blood was diluted 5-fold with
aqueous sodium ascorbate (10 g/l) and stored at - 358. The
haemolysates were further diluted with IMx Folate RBC
Lysis Reagent (Abbott Laboratories, North Chicago, IL,
USA). To enable expression of the folate concentration in
erythrocytes, packed cell volumes were also measured.
For methionine analysis a quantitative amino acid analy-
sis in plasma was performed on a Biotronik 7000 amino
acid analyser (Biotronik, Maintal, Federal Republic of
Germany) using S-(aminoethyl)cysteine as internal stan-
dard. The separation was achieved by a stepwise gradient
of lithium citrate buffers; the detection and quantification
was performed with the classical ninhydrin reaction and
spectrophotometry at 440 and 570 nm. The method had
inter- and intra-assay CV , 5 %.
Plasma tHcy was measured by an HPLC technique and
fluorimetric detection (intra- and inter-assay CV , 8 %)
(Araki & Sako, 1987). Folate concentrations in plasma
and erythrocytes and vitamin B12 in plasma were deter-
mined with the Abbott IMx Vitamin B12 and Folic Acid
assays (Abbott Laboratories). The intra-assay CV of the
folate assay was , 6 %, while the inter-assay CV was ,
10 %. For vitamin B12, both the intra- and inter-assay CV
were lower than 5 %.
Statistics
The response to treatment was calculated for each subject as
the change in plasma methionine, tHcy and plasma vitamin
B12 concentrations between the start (week 0) and the end of
the intervention period (week 4). These responses were
normally distributed as checked by visual inspection of
the normal probability plots (univariate procedure; Statis-
tical Analysis Systems Inc., Cary, NC, USA). To analyse
differences in response to intervention Student’s t tests
were used with a significance level of P , 0 × 05/3 = 0 × 017.
Spearman rank correlation coefficients were calculated
for the blood variables, because the concentrations (with
the exception of plasma methionine) were not normally
distributed.
Results
Low-dose folic acid supplementation for 4 weeks had no
effect on plasma methionine concentrations, whereas folate
concentrations in plasma and erythrocytes increased and
plasma tHcy concentrations decreased (Table 1; Brouwer
et al. 1999). Intervention with folic acid had no effect on
plasma vitamin B12 concentrations (Table 1).
The mean change in plasma methionine in the 500 mg
group corrected for the change in the placebo group was
0 × 37 (95 % CI - 1 × 6, 2 × 3) mmol/l; the mean change in plasma
methionine in the 250 mg group corrected for the change
in the placebo group was - 1 × 2 (95 % CI - 3 × 2, 0 × 7) mmol/l.
Fig. 1 shows the individual values of plasma methionine and
plasma tHcy before and after intervention.
Baseline plasma tHcy and methionine concentrations of
the subjects were not correlated (Spearman rs - 0 × 01, P =
0 × 89). Baseline plasma tHcy concentrations showed a
slight, but significant correlation with baseline concentra-
tions of plasma vitamin B12 (rs - 0 × 25, P = 0 × 003), plasma
folate (rs - 0 × 24, P = 0 × 004) and erythrocyte folate (rs - 0 × 19,
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P = 0 × 03). However, none of these blood vitamin concentra-
tions was correlated with plasma methionine concentrations.
Users of oral contraceptives (n 97) had significantly
lower baseline plasma vitamin B12 concentrations (252
(SD 84) pmol/l than non-users (346 (SD 118) pmol/l).
However, no differences were observed for plasma tHcy
and folate concentrations between users and non-users of
oral contraceptives.
Discussion
This present study shows that 4 weeks of low-dose folic acid
supplementation did not influence plasma methionine or
plasma vitamin B12 concentrations although it decreased
plasma tHcy concentrations and increased plasma and
erythrocyte folate concentrations (Brouwer et al. 1999).
Plasma methionine concentrations were also not correlated
with tHcy or plasma or erythrocyte folate concentrations,
while tHcy concentrations were inversely correlated with
these blood vitamin variables.
In contrast to our study, Guttormsen et al. (1996) showed
significantly increased fasting plasma methionine concen-
trations after intervention with folic acid (5 mg/d for 10 d)
and/or intramuscular injections with cobalamin (3–5 mg in
2–3 weeks). However, they supplied much higher doses of
folic acid and all subjects in that study had a deficient or
marginal folate and vitamin B12 status and elevated plasma
tHcy concentrations (Guttormsen et al. 1996). Our results
are supported by those of others who also showed no effects
of increased folate intake on plasma methionine concentra-
tions in healthy young men, although plasma tHcy concen-
trations increased after depletion and decreased after
repletion (Jacob et al. 1994, 1995; Ubbink et al. 1995).
All our subjects had plasma methionine concentrations in
the normal range (Scriver et al. 1985), but they were not in
optimal folate status because folic acid supplementation
decreased their plasma tHcy concentrations (Brouwer et al.
1999). Effects of folic acid supplementation might be
different in subjects with either high or low plasma methio-
nine and tHcy concentrations. Repetition of the analysis
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Table 1. Plasma folate, erythrocyte folate, plasma vitamin B12, total plasma homocysteine and plasma methionine
concentrations before and after 4 weeks of folic acid supplementation
(Values are means and standard deviations)
500 mg folic acid/d 250 mg folic acid/d Placebo group
group (n 45) group (n 50) (n 49)
Mean SD Mean SD Mean SD
Initial plasma folate (nmol/l) 11 4× 0 11 3× 4 12 4× 2
Final plasma folate (nmol/l) 27 5× 1 23 5× 3 17 6× 1
Initial erythrocyte folate (nmol/l) 400 107 386 85 422 181
Final erythrocyte folate (nmol/l) 508 176 432 126 401 182
Initial plasma vitamin B12 (nmol/l) 265 117 290 88 286 110
Final plasma vitamin B12 (pmol/l) 265 110 300 98 287 121
Initial total plasma homocysteine (mmol/l) 11× 1 2× 6 9× 7 2× 2 10× 4 2× 5
Final total plasma homocysteine (mmol/l) 8× 5 1× 7 8× 5 1× 7 10× 3 2× 5
Initial plasma methionine (mmol/l) 22× 6 4× 8 23× 4 4× 3 23× 4 4× 1
Final plasma methionine (mmol/l) 23× 7 5× 7 22× 9 4× 3 24× 1 4× 7
Fig. 1. Changes in (a) plasma methionine and (b) plasma total homocysteine (tHcy) in healthy young women (n 144) after four weeks of placebo
(W), 250 mg folic acid/d (A) or 500 mg folic acid/d (K).
with exclusion of those subjects with plasma tHcy concen-
trations above 15 mmol/l did not change the results of the
current study.
Potgieter et al. (1997) noticed that methionine is very
sensitive to oxidation and may even be converted to
methionine sulfoxide when samples are stored at - 208
until analysis. Thus, in our study spontaneous oxidation
of methionine might have occurred and it can not be
excluded that this contributed to the lack of effect on
plasma methionine.
Differences in methionine intake between the groups is
not a very likely explanation for the lack of effect in the
present study. Although we did not estimate methionine
intake in the subjects, we know from a 24 h recall from all
participants during the trial that the total dietary protein
intake and the intake of animal protein reflected by the
vitamin B12 intake were similar among the groups (Brouwer
et al. 1999). This suggests comparable methionine intakes
between the groups. Besides, it is unlikely that a slight
difference in methionine intake would have influenced
plasma methionine concentrations: Jacob et al. (1995)
showed that changes in the intake of dietary methyl
groups did not influence plasma methionine concentrations.
Moreover, Andersson et al. (1990) found that a 3-fold
increase in the daily intake of methionine for 13 d had no
effect on fasting plasma methionine concentrations on day
14.
On the basis of the actual group sizes (placebo group, n
49; 500 mg/d group, n 45) and the standard deviations for the
change in plasma methionine (placebo group, 4× 8; 500 mg/d
group, 5 × 1) and a power of 90 %, we calculated that a
difference of 3 × 3 mmol/l in plasma methionine between the
placebo and the 500 mg/d group would have been statisti-
cally significant. Therefore, we can exclude effects of low-
dose folic acid supplementation on methionine above this
level.
We found no effect of folic acid supplementation on
plasma vitamin B12 concentrations. However, users of oral
contraceptives had a lower plasma vitamin B12 concentra-
tion than non-users at baseline. Plasma tHcy concentrations
were not affected by use of oral contraceptives. Green et al.
(1998) also found lower (33 %) plasma vitamin B12 con-
centrations, but similar plasma tHcy concentrations in
adolescent females who used oral contraceptives than
those who did not use oral contraceptives. Our study
suggests that this finding is not just confined to adolescent
females.
In conclusion, fasting plasma methionine levels in
healthy women were not related to plasma folate and
vitamin B12 concentrations and were not influenced by
low-dose folic acid supplementation.
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